[Oral contraception in patients with heart disease].
D000032:Abortion, Therapeutic; D000328:Adult; D001022:Aortic Valve Insufficiency / Q000150:complications; D002908:Chronic Disease; D004077:Digoxin / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D006331:Heart Diseases / Q000150:complications*; D006333:Heart Failure / Q000150:complications*; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D008134:Long-Term Care; D008234:Lynestrenol / Q000008:administration & dosage* / Q000009:adverse effects; D008656:Mestranol / Q000008:administration & dosage* / Q000009:adverse effects; D008944:Mitral Valve Insufficiency / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control
D004338:Drug Combinations; D004077:Digoxin; D008656:Mestranol; D008234:Lynestrenol
Orale Kontrazeption bei Herzpatientinnen.